Central Nervous System Metastasis

• Central Nervous System Metastasis occurs when cancer spreads to the brain or spinal cord from a primary tumor elsewhere in the body.
• Common primary cancers that metastasize to the CNS include lung, breast, and melanoma.
• Symptoms vary widely depending on the location and size of the metastatic lesions, often including headaches, seizures, and neurological deficits.
• Diagnosis typically involves imaging techniques like MRI and may include biopsy.
• Treatment strategies are multidisciplinary, focusing on symptom control, improving quality of life, and extending survival through options like surgery, radiation, and systemic therapies.

What is Central Nervous System Metastasis?

Central Nervous System Metastasis (CNS metastasis) is a condition where cancer cells originating from a primary tumor in another organ, such as the lung or breast, travel through the bloodstream or lymphatic system and establish new tumors within the brain or spinal cord. This process, known as metastasis, represents a significant challenge in oncology due to the delicate and vital functions of the central nervous system.

The development of CNS metastasis is a complex biological event, and the specific primary cancers that lead to causes of brain and spinal cord metastasis vary. According to the American Association of Neurological Surgeons (AANS), brain metastases are the most common intracranial tumor in adults, occurring in 10% to 30% of adult cancer patients. The most common primary cancers that metastasize to the CNS include:

• Lung cancer (both small cell and non-small cell)
• Breast cancer
• Melanoma
• Kidney cancer (renal cell carcinoma)
• Colorectal cancer

Understanding the origin of the metastasis is crucial for guiding treatment decisions and predicting prognosis. The presence of these secondary tumors can disrupt normal neurological function, leading to a range of symptoms that require immediate medical attention.

Common Symptoms of CNS Metastasis

The symptoms of CNS metastasis are diverse and depend heavily on the location, size, and number of metastatic lesions within the brain or spinal cord. As the tumors grow, they can exert pressure on surrounding brain tissue, interfere with nerve signals, or cause inflammation, leading to a variety of neurological impairments. Symptoms often develop gradually but can sometimes appear suddenly.

For brain metastases, common symptoms may include persistent headaches, which can be severe and worsen over time, often accompanied by nausea and vomiting. Seizures are also a frequent manifestation, ranging from subtle changes in awareness to full-body convulsions. Other brain-related symptoms can involve changes in cognitive function, such as memory loss, confusion, or difficulty concentrating. Motor deficits like weakness or numbness on one side of the body, balance problems, and vision changes (e.g., double vision, blurred vision) are also common. For spinal cord metastases, symptoms often include back pain that may radiate to the limbs, weakness in the legs or arms, numbness, tingling, or difficulty with bladder and bowel control.

Managing Central Nervous System Metastasis: Treatment Options

The management of treatment for central nervous system metastasis is highly individualized, depending on the type of primary cancer, the number and location of metastases, the patient’s overall health, and previous treatments. The primary goals of treatment are to control symptoms, improve quality of life, and extend survival. A multidisciplinary team, including neurosurgeons, radiation oncologists, medical oncologists, and neurologists, typically collaborates to develop the most effective treatment plan.

Treatment options often include a combination of modalities. Surgery may be considered for single, accessible tumors, especially if they are causing significant symptoms or if a tissue diagnosis is needed. Radiation therapy is a cornerstone of treatment, with options such as whole-brain radiation therapy (WBRT) for multiple lesions or stereotactic radiosurgery (SRS) for a limited number of smaller tumors, which delivers highly focused radiation with minimal damage to surrounding healthy tissue. Systemic therapies, including chemotherapy, targeted therapy, and immunotherapy, are also increasingly used. These treatments aim to kill cancer cells throughout the body, including those in the CNS, and are often chosen based on the specific characteristics of the primary cancer and its molecular profile.

Supportive care, including pain management, anti-seizure medications, and corticosteroids to reduce swelling, is also crucial for managing symptoms and improving patient comfort. While these supportive measures can significantly alleviate discomfort, it is important to note that they do not replace definitive medical treatment for the underlying cancer.